Literature DB >> 12048075

Cardioprotection by breathing hyperoxic gas-relation to oxygen concentration and exposure time in rats and mice.

P Tähepõld1, A Ruusalepp, G Li, J Vaage, J Starkopf, G Valen.   

Abstract

OBJECTIVES: Breathing a hyperoxic gas (> or =95% O(2)) protects against ischaemia-reperfusion injury in rat and mouse hearts. The present study investigated how oxygen concentration and duration of hyperoxic exposure influenced cardioprotection, and whether hyperoxia might induce delayed cardioprotection (after 24 h).
METHODS: Animals were kept in normal air or in a hyperoxic environment, and their hearts were isolated and Langendorff-perfused immediately or 24 h thereafter. Global ischaemia was induced for 25 min in rats and 40 min in mice, followed by 60 min of reperfusion. Infarct size was determined by triphenyl tetrazolium chloride staining.
RESULTS: In rats exposure to > or =95, 80, and 60%, but not to 40% of oxygen immediately before heart isolation and perfusion improved postischaemic functional recovery. Eighty or more percent of oxygen also reduced infarct size. A preconditioning-like effect could be evoked by 60 or 180 min of hyperoxia, giving both immediate and delayed protection. In the mouse heart protection could be induced by pretreatment for 15 or 30, but not by 60 min with > or =95% oxygen. The protective effect of hyperoxia in mice could be evoked in the immediate model only.
CONCLUSIONS: Hyperoxia protects the isolated rat and mouse heart against ischaemia-reperfusion injury, but some species-different responses exist. The protection depends on both oxygen concentration in inspired air, and duration of hyperoxic exposure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048075     DOI: 10.1016/s1010-7940(02)00125-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Hyperoxia during early reperfusion does not increase ischemia/reperfusion injury.

Authors:  Lars Henrik Mariero; Arkady Rutkovskiy; Kåre-Olav Stensløkken; Jarle Vaage
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Mitochondrial quality-control dysregulation in conditional HO-1-/- mice.

Authors:  Hagir B Suliman; Jeffrey E Keenan; Claude A Piantadosi
Journal:  JCI Insight       Date:  2017-02-09

3.  Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial.

Authors:  Osama Abou-Arab; Pierre Huette; Lucie Martineau; Clémence Beauvalot; Christophe Beyls; Estelle Josse; Gilles Touati; Olivier Bouchot; Belaïd Bouhemad; Momar Diouf; Emmanuel Lorne; Pierre-Grégoire Guinot
Journal:  Intensive Care Med       Date:  2019-10-01       Impact factor: 17.440

4.  Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery.

Authors:  Tomas B Corcoran; Anne E Barden; Emilie Mas; Sina Grape; Viktoria Koren; Michael Phillips; L Jackson Roberts; Trevor A Mori
Journal:  Free Radic Biol Med       Date:  2011-06-27       Impact factor: 7.376

5.  Effects of 60 minutes of hyperoxia followed by normoxia before coronary artery bypass grafting on the inflammatory response profile and myocardial injury.

Authors:  Inga Karu; Peeter Tähepõld; Arno Ruusalepp; Kersti Zilmer; Mihkel Zilmer; Joel Starkopf
Journal:  J Negat Results Biomed       Date:  2012-09-14

6.  Hyperoxic preconditioning fails to confer additional protection against ischemia-reperfusion injury in acute diabetic rat heart.

Authors:  Khalil Pourkhalili; Sohrab Hajizadeh; Zahra Akbari; Mansour Esmaili Dehaj; Samad Akbarzadeh; Alimohammad Alizadeh
Journal:  EXCLI J       Date:  2012-06-11       Impact factor: 4.068

7.  Influence of Hypoxic and Hyperoxic Preconditioning on Endothelial Function in a Model of Myocardial Ischemia-Reperfusion Injury with Cardiopulmonary Bypass (Experimental Study).

Authors:  Irina A Mandel; Yuri K Podoksenov; Irina V Suhodolo; Darya A An; Sergey L Mikheev; Andrey Yu Podoksenov; Yulia S Svirko; Anna M Gusakova; Vladimir M Shipulin; Andrey G Yavorovskiy
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.